Oncology Medical Writing Svcs Inc - NY New York, New York City 10023

Oncology Medical Writing Svcs Inc entered the industry of Services (Unclassified) in 2009 and has grown to employ 1 to 4 people, generating an annual revenue of $0 to $49.999. The NAICS classifies this business under the code 541990, which describes it as a Services (Unclassified). For further clarification, the SIC classifies this business under the code 8999 and described it as a Services (Unclassified). The business provides service to the B2B market.

To acquire more information, please contact Susan Kralian by calling (212) 362-3891 during business hours. You can also write to the business’ Single Location at 239 West 63rd St Apartment 1e, New York City, New York NY 10023. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Oncology Medical Writing Svcs Inc
Representative: Susan Kralian
Place of Business: 239 West 63rd St Apartment 1e, New York City, NY 10023
Contact Number: (212) 362-3891
Type of Service: Services (Unclassified)
SIC Number: 8999
NAICS Number: 541990
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2009
Income/Year: $0 to $49.999
Laborers: 1 to 4
Share This Company:

Oncology Medical Writing Svcs Inc is a company operating from New York, New York providing professional Services (Unclassified) and relevant B2B variables. It was founded in 2009 and registered with the SIC code 8999 as Services (Unclassified), and with the NAICS code 541990 as Services (Unclassified).

With a current employee count of 1 to 4, Oncology Medical Writing Svcs Inc has gone to report making $0 to $49.999 per annum on its journey towards growth. This company invites you to contact its representative Susan Kralian at (212) 362-3891 for related queries, or to locate its Single Location using the coordinates .

The Single Location can also be found at the street address 239 West 63rd St Apartment 1e in New York City, New York 10023 and can be engaged online through the company website at , the company Twitter , and Facebook page .